Search Results

Filter
  • 1-10 of  96,415 results for ""MIFEPRISTONE""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Risk of teratogenicity in continued pregnancy after gestational exposure to mifepristone and/or misoprostol: a systematic review and meta-analysis.

  • Authors : Jingran G; Obstetrics and Gynecology Hospital, Fudan University, Shanghai, 200011, People's Republic of China.; Yan D

Subjects: Misoprostol*/Misoprostol*/Misoprostol*/adverse effects ; Misoprostol*/Misoprostol*/Misoprostol*/administration & dosage ; Mifepristone*/Mifepristone*/Mifepristone*/adverse effects

  • Source: Archives of gynecology and obstetrics [Arch Gynecol Obstet] 2024 Sep; Vol. 310 (3), pp. 1331-1342. Date of Electronic Publication: 2024 Jul 09.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8710213 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Congenital and Fetal Effects After Mifepristone Exposure and Continuation of Pregnancy: A Systematic Review.

  • Authors : Turner JV; School of Rural Medicine, University of New England, Armidale, New South Wales, Australia.; Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.

Subjects: Abnormalities, Drug-Induced*/Abnormalities, Drug-Induced*/Abnormalities, Drug-Induced*/epidemiology ; Abnormalities, Drug-Induced*/Abnormalities, Drug-Induced*/Abnormalities, Drug-Induced*/etiology ; Abortifacient Agents, Steroidal*/Abortifacient Agents, Steroidal*/Abortifacient Agents, Steroidal*/adverse effects

  • Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Nov; Vol. 116 (5), pp. 1207-1216. Date of Electronic Publication: 2024 Jul 25.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535

Record details

×
Academic Journal

Availability of mifepristone and misoprostol in Oregon pharmacies: A comparison by rural and urban status.

  • Authors : Mnuk R; Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, OR, United States. Electronic address: .; Schrote K

Subjects: Misoprostol*/Misoprostol*/Misoprostol*/supply & distribution ; Misoprostol*/Misoprostol*/Misoprostol*/administration & dosage ; Mifepristone*/Mifepristone*/Mifepristone*/supply & distribution

  • Source: Contraception [Contraception] 2024 Sep; Vol. 137, pp. 110491. Date of Electronic Publication: 2024 May 18.Publisher: Elsevier Country of Publication: United States NLM ID: 0234361 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Targeting delivery of mifepristone to endometrial dysfunctional macrophages for endometriosis therapy.

  • Authors : Zhang M; Department of Pharmacy, Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China.; Ye Y

Subjects: Endometriosis*/Endometriosis*/Endometriosis*/drug therapy ; Endometriosis*/Endometriosis*/Endometriosis*/pathology ; Macrophages*/Macrophages*/Macrophages*/drug effects

  • Source: Acta biomaterialia [Acta Biomater] 2024 Nov; Vol. 189, pp. 505-518. Date of Electronic Publication: 2024 Sep 26.Publisher: Elsevier Country of Publication: England NLM ID: 101233144 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-7568

Record details

×
Academic Journal

Outcomes After Early Pregnancy Loss Management With Mifepristone Plus Misoprostol vs Misoprostol Alone.

  • Authors : Benson LS; Department of Obstetrics and Gynecology, University of Washington School of Medicine, Seattle.; Gunaje N

Subjects: Misoprostol*/Misoprostol*/Misoprostol*/therapeutic use ; Misoprostol*/Misoprostol*/Misoprostol*/administration & dosage ; Mifepristone*/Mifepristone*/Mifepristone*/therapeutic use

  • Source: JAMA network open [JAMA Netw Open] 2024 Oct 01; Vol. 7 (10), pp. e2435906. Date of Electronic Publication: 2024 Oct 01.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet

Record details

×
Academic Journal

The Success of Mifepristone and Misoprostol in the Management of Early Pregnancy Loss at a Community Hospital: A Prospective Study.

  • Authors : Farooqi S; Department of Obstetrics and Gynaecology, University of Toronto, Toronto, ON. Electronic address: .; Lackie E

Subjects: Mifepristone*/Mifepristone*/Mifepristone*/administration & dosage ; Mifepristone*/Mifepristone*/Mifepristone*/therapeutic use ; Misoprostol*/Misoprostol*/Misoprostol*/administration & dosage

  • Source: Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC [J Obstet Gynaecol Can] 2024 Sep; Vol. 46 (9), pp. 102604. Date of Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101126664 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Mifepristone and misoprostol in California pharmacies after modifications to the Risk Evaluation and Mitigation Strategy Program.

  • Authors : Beshar I; Department of Obstetrics & Gynecology, Stanford University, Palo Alto, CA, USA. Electronic address: .; Miller HE

Subjects: Misoprostol*/Misoprostol*/Misoprostol*/administration & dosage ; Mifepristone*/Mifepristone*/Mifepristone*/administration & dosage ; Pharmacies*

  • Source: Contraception [Contraception] 2024 Sep; Vol. 137, pp. 110506. Date of Electronic Publication: 2024 May 26.Publisher: Elsevier Country of Publication: United States NLM ID: 0234361 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

Progesterone treatment for women who have changed their minds after taking mifepristone.

  • Authors : Hassan J; General Practitioner, Nelson, New Zealand.; Ng M

Subjects: Mifepristone*/Mifepristone*/Mifepristone*/therapeutic use ; Progesterone*/Progesterone*/Progesterone*/therapeutic use ; Progesterone*/Progesterone*/Progesterone*/adverse effects

  • Source: The New Zealand medical journal [N Z Med J] 2024 Sep 06; Vol. 137 (1602), pp. 137-139. Date of Electronic Publication: 2024 Sep 06.Publisher: Pasifika Medical Association Group Country of Publication: New Zealand NLM ID: 0401067 Publication Model: Electronic Cited Medium: Internet

Record details

×
Academic Journal

Mifepristone protects acetaminophen induced liver injury through NRF2/GSH/GST mediated ferroptosis suppression.

  • Authors : Shi Y; GuiZhou University Medical College, Guiyang, 550025, China.; Xu N

Subjects: Ferroptosis*/Ferroptosis*/Ferroptosis*/drug effects ; NF-E2-Related Factor 2*/NF-E2-Related Factor 2*/NF-E2-Related Factor 2*/metabolism ; NF-E2-Related Factor 2*/NF-E2-Related Factor 2*/NF-E2-Related Factor 2*/genetics

  • Source: Free radical biology & medicine [Free Radic Biol Med] 2024 Sep; Vol. 222, pp. 229-243. Date of Electronic Publication: 2024 Jun 19.Publisher: Elsevier Science Country of Publication: United States NLM ID: 8709159 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Access to mifepristone, misoprostol, and contraceptive medicines in eight countries in the Eastern Mediterranean Region: descriptive analyses of country-level assessments.

  • Authors : Afifi M; World Health Organization, Regional Office for the Eastern Mediterranean, Cairo, Egypt. .; Hemachandra N

Subjects: Misoprostol*/Misoprostol*/Misoprostol*/supply & distribution ; Misoprostol*/Misoprostol*/Misoprostol*/therapeutic use ; Health Services Accessibility*

  • Source: Reproductive health [Reprod Health] 2024 Jun 04; Vol. 20 (Suppl 1), pp. 192. Date of Electronic Publication: 2024 Jun 04.Publisher: BioMed Central Country of Publication: England NLM ID: 101224380 Publication Model: Electronic Cited Medium: Internet ISSN: 1742-4755

Record details

×
  • 1-10 of  96,415 results for ""MIFEPRISTONE""